Quick Answer
Absci Corp reported Research And Development Expense of $81.42 million for the year ending 2025.
- Absci Corp showed an increase of +27.5% in Research And Development Expense from 2024 to 2025.
- This data is from Absci Corp's annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $2.25 million | Q3 2020: $2.69 million | Q1 2021: $7.05 million | Q2 2021: $11.04 million | Q3 2021: $10.73 million | Q1 2022: $15.83 million | Q2 2022: $16.24 million | Q3 2022: $15.53 million | Q1 2023: $12.66 million | Q2 2023: $12.11 million | Q3 2023: $11.03 million | Q1 2024: $12.24 million | Q2 2024: $15.26 million | Q3 2024: $17.99 million | Q1 2025: $16.36 million | Q2 2025: $20.46 million | Q3 2025: $19.25 million.
- Over the full 6 years of available data (2020 to 2025), Absci Corp's Research And Development Expense has grown by 611.2%.
- Historical annual values: Fiscal year 2025: $81.42 million | Fiscal year 2024: $63.86 million | Fiscal year 2023: $48.07 million | Fiscal year 2022: $58.91 million | Fiscal year 2021: $44.59 million | Fiscal year 2020: $11.45 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: